why choose us

First received: April 27, 2024

Clinical Trial: Biomarkers of Steatohepatitis in Type 2 Diabetes Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes
Steatosis of Liver

Study Type: OBSERVATIONAL


Official Title: Biomarkers of Steatohepatitis in Type 2 Diabetes Patients

Brief Summary: The aims of the study are to identify a subgroup of type 2 diabetics at risk of developing and progressing to non-alcoholic steatohepatitis (NASH), to correlate clinical and laboratory parameters with sonographic and elastographic findings in order to pinpoint indicators of liver fibrosis (NASH), and to facilitate targeted screening and intensified management of type 2 diabetes mellitus to prevent NASH complications.

Read more